HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter K Todd Selected Research

Guillain-Barre Syndrome

1/2022Guillain-Barré Syndrome After COVID-19 mRNA Vaccination in a Liver Transplantation Recipient With Favorable Treatment Response.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter K Todd Research Topics

Disease

27Fragile X Tremor Ataxia Syndrome
01/2023 - 03/2010
20Neurodegenerative Diseases (Neurodegenerative Disease)
11/2023 - 03/2010
5Myotonic Dystrophy (Dystrophia Myotonica)
01/2021 - 03/2010
5Fragile X Syndrome (Martin Bell Syndrome)
01/2021 - 02/2003
4Frontotemporal Dementia (Semantic Dementia)
01/2021 - 10/2014
3Neoplasms (Cancer)
01/2022 - 01/2019
3Intellectual Disability (Idiocy)
01/2021 - 02/2003
3Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2021 - 10/2014
1X-Linked Torsion Dystonia 3
11/2022
1Dysbiosis
01/2022
1COVID-19
01/2022
1Colonic Neoplasms (Colon Cancer)
01/2022
1Inflammation (Inflammations)
01/2022
1Colorectal Neoplasms (Colorectal Cancer)
01/2022
1Guillain-Barre Syndrome
01/2022
1Ataxia (Dyssynergia)
01/2021
1Huntington Disease (Huntington's Disease)
01/2021
1Nervous System Diseases (Neurological Disorders)
10/2014
1Spinocerebellar Ataxias (Spinocerebellar Ataxia)
10/2014
1Cerebellar Ataxia (Dysmetria)
04/2014
1Infections
04/2014
1Alzheimer Disease (Alzheimer's Disease)
01/2014
1Proteostasis Deficiencies
05/2012

Drug/Important Bio-Agent (IBA)

135' Untranslated Regions (5' UTR)IBA
01/2023 - 12/2010
12Proteins (Proteins, Gene)FDA Link
11/2023 - 03/2010
9RNA (Ribonucleic Acid)IBA
01/2022 - 03/2010
6Peptides (Polypeptides)IBA
01/2022 - 01/2016
4Messenger RNA (mRNA)IBA
01/2022 - 03/2010
4NucleotidesIBA
12/2019 - 11/2011
4Fragile X Mental Retardation ProteinIBA
01/2014 - 02/2003
3UbiquitinIBA
10/2019 - 05/2013
3Initiator Codon (Start Codon)IBA
01/2019 - 01/2016
3RNA-Binding Proteins (RNA-Binding Protein)IBA
10/2014 - 02/2003
2Peptide Initiation Factors (Initiation Factor)IBA
01/2023 - 01/2022
2AntibodiesIBA
10/2019 - 12/2016
23' Untranslated Regions (3' UTR)IBA
11/2014 - 01/2014
1Eukaryotic Initiation Factor-4G (Eukaryotic Initiation Factor 4G)IBA
01/2023
1GuanineIBA
12/2022
1CytosineIBA
12/2022
1Retroelements (Retrotransposon)IBA
11/2022
13-hydroxypropionaldehydeIBA
01/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022
1polyglutamineIBA
01/2021
1Eukaryotic Initiation FactorsIBA
01/2019
1RNA Helicases (RNA Helicase)IBA
01/2019
1Coloring Agents (Dyes)IBA
12/2016
1polyprolineIBA
12/2016
1polyalanineIBA
12/2016
1ran GTP-Binding ProteinIBA
12/2016
1RNA Precursors (Precursor, mRNA)IBA
01/2016
1Proteasome Endopeptidase Complex (Proteasome)IBA
08/2015
1Protein Kinases (Protein Kinase)IBA
11/2014
1DNA-Binding Proteins (DNA Binding Protein)IBA
10/2014
1hnRNP A2IBA
10/2014
1Rituximab (Mabthera)FDA Link
04/2014
1Natalizumab (Tysabri)FDA Link
04/2014
1MicroRNAs (MicroRNA)IBA
03/2013
1Histone Deacetylases (Histone Deacetylase)IBA
12/2010

Therapy/Procedure

2Therapeutics
01/2022 - 04/2014
1Liver Transplantation
01/2022